Great Tree Pharmacy Co., Ltd. (TPEX:6469)
Taiwan · Delayed Price · Currency is TWD 69.50
+1.30 (1.91%)
Oct 16, 2026, 1:30 PM CST
Great Tree Pharmacy Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 10,429 | 14,007 | 19,256 | 39,040 | 26,339 | 15,725 | |
Market Cap Growth | -39.91% | -27.26% | -50.68% | 48.22% | 67.50% | 209.64% |
Enterprise Value | 14,461 | 18,853 | 22,566 | 41,523 | 28,548 | 17,877 |
Last Close Price | 69.50 | 84.70 | 114.37 | 230.56 | 156.83 | 93.98 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 22.04 | 23.33 | 28.29 | 58.62 | 37.62 | 38.60 |
Forward PE | 27.15 | 17.47 | 23.55 | 44.87 | 36.33 | 21.17 |
PS Ratio | 0.55 | 0.74 | 1.12 | 2.42 | 1.81 | 1.39 |
PB Ratio | 2.79 | 3.50 | 5.28 | 11.65 | 10.04 | 8.05 |
P/TBV Ratio | 2.91 | 3.66 | 5.44 | 12.06 | 10.24 | 8.23 |
P/FCF Ratio | 16.92 | 16.69 | 24.70 | 65.72 | 28.51 | 18.96 |
P/OCF Ratio | 11.18 | 12.02 | 16.91 | 43.85 | 21.47 | 14.59 |
PEG Ratio | - | 1.38 | 1.38 | 2.24 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.76 | 1.00 | 1.31 | 2.57 | 1.96 | 1.59 |
EV/EBITDA Ratio | 10.37 | 19.65 | 21.10 | 39.71 | 26.66 | 26.96 |
EV/EBIT Ratio | 27.71 | 27.35 | 28.17 | 51.55 | 33.12 | 36.31 |
EV/FCF Ratio | 23.46 | 22.47 | 28.94 | 69.90 | 30.90 | 21.56 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.72 | 1.59 | 1.49 | 1.32 | 1.72 | 1.66 |
Debt / EBITDA Ratio | 4.61 | 4.11 | 3.43 | 2.96 | 3.09 | 3.28 |
Debt / FCF Ratio | 10.44 | 7.58 | 6.97 | 7.45 | 4.89 | 3.91 |
Net Debt / Equity Ratio | 1.06 | 0.97 | 0.89 | 0.68 | 0.79 | 0.99 |
Net Debt / EBITDA Ratio | 5.05 | 4.04 | 3.02 | 2.19 | 1.92 | 2.92 |
Net Debt / FCF Ratio | 6.43 | 4.62 | 4.14 | 3.85 | 2.23 | 2.33 |
Asset Turnover | 1.40 | 1.46 | 1.51 | 1.55 | 1.66 | 1.68 |
Inventory Turnover | 3.67 | 3.93 | 4.17 | 4.30 | 4.72 | 5.05 |
Quick Ratio | 0.68 | 0.77 | 0.67 | 0.92 | 0.92 | 0.65 |
Current Ratio | 1.49 | 1.63 | 1.38 | 1.80 | 1.75 | 1.33 |
Return on Equity (ROE) | 13.46% | 15.20% | 19.43% | 22.30% | 30.61% | 23.49% |
Return on Assets (ROA) | 2.40% | 3.33% | 4.37% | 4.82% | 6.15% | 4.59% |
Return on Invested Capital (ROIC) | 5.50% | 7.30% | 10.28% | 12.35% | 15.97% | 10.44% |
Return on Capital Employed (ROCE) | 6.00% | 7.50% | 10.80% | 10.80% | 12.60% | 10.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.95% | 4.29% | 3.54% | 1.71% | 2.66% | 2.59% |
FCF Yield | 5.91% | 5.99% | 4.05% | 1.52% | 3.51% | 5.27% |
Dividend Yield | 4.29% | 3.38% | 2.26% | 1.03% | 1.59% | 1.15% |
Payout Ratio | 84.67% | 72.73% | 59.57% | 63.44% | 26.03% | 13.12% |
Buyback Yield / Dilution | -6.67% | -2.67% | 0.75% | -3.19% | -1.51% | -3.36% |
Total Shareholder Return | -2.38% | 0.71% | 3.01% | -2.15% | 0.08% | -2.21% |